Contact Us

Case Review Form
*    Denotes required field.

Describe accident or indicate name of drug or device

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Please describe your case:

Date of Incident : 

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Medtronic SynchroMed Implantable Pump Recall


AddThis Social Bookmark Button

Medtronic SynchroMed Implantable Infusion Pump Recall Side Effects Could Be Associated Personal Injury Lawsuits

Medtronic SynchroMed Implantable Infusion Pump Recall | Lawsuits, Lawyers | Side Effects: Serious Injury, Death | Gear Shaft Wear, Defective Medical Devices

In August 2007, Medtronic Inc. SynchroMed El Implantable Infusion Pumps were the subject of a Class I Food & Drug Administration (FDA) recall. According to the FDA recall notice posted on the agency’s website in February 2008, the Medtronic SynchroMed El Implantable Infusion Pumps stall at an unusually high rate, putting patients at risk of serious injury or even death. The FDA only issues Class I recalls when there is a reasonable probability that use of a defective medical device will cause serious injury or death.

According to the FDA, the Medtronic Inc. SynchroMed El Implantable Infusion Pump administers drugs to a specific site in the body to treat pain, spasticity (continuous muscle contraction), and cancer. The pump is implanted in the patient, either with or without a side catheter access port, catheters, and catheter accessories.

The implantable Medtronic SynchroMed EL Programmable Pump is part of the SynchroMed EL Infusion System. The Medtronic SynchroMed El Implantable Infusion Pump recall involved models 8626-10, 8626L-10, 8626-18, 8626L-18, 8627-10, 8627L-10, 8627-18, and 8627L-18. Only those models with motors manufactured before September 1999 are affected by the recall.

The Medtronic SynchroMed El Implantable Infusion Pumps can stall at a higher rate due to gear shaft wear. If a pump motor stalls, drug delivery will stop suddenly and without warning. This stoppage will result in loss of therapy, return of the patient’s symptoms, and/or symptoms of drug underinfusion or withdrawal. According to the FDA, drug withdrawal from Intrathecal Baclofen (ITB) therapy (in the patient’s spine) can cause death if not treated immediately and effectively.

According to the FDA recall notice, Medtronic notified its customers of the SynchroMed El Implantable Infusion Pump via a letter dated August 3, 2007.

Legal Help For Victims Affected By Medtronic SynchroMed Implantable Infusion Pump Recall

If you or a loved one where injured as a result of a defective Medtronic SynchroMed El Implantable Infusion Pump, you have valuable legal rights. Please fill out our online form or call 1-800-LAW-INFO (1-800-529-4636) for a free case evaluation by a qualified medical device attorney.

Medtronic SynchroMed Implantable Pump RecallRSS Feed

SynchroMed II Infusion Pumps Recalled by Medtronic Over Battery Defect

Sep 13, 2011 | Parker Waichman LLP
Medtronic Inc.’s Model 837 SynchroMed II Infusion pumps have been named in a Class I recall, according to the U.S. Food & Drug Administration (FDA).  The affected SynchroMed II Infusion pumps could suffer from reduced battery function, leading to the sudden loss of therapy and the return of underlying symptoms and/or withdrawal symptoms. This recall includes the SynchroMed II Implantable Infusion Pump models 8637-20 and 8637-40, distributed between May 2004 and July 8,...

Medtronic Unit Settles Defective Spine Device Lawsuit

Apr 29, 2011 | Parker Waichman LLP
A lawsuit involving the Danek 3-D TSRH Spinal System made by a unit of Medtronic Inc.  has been settled, according to a report from Law360.   The lawsuit was brought by a Puerto Rican woman and her family who claimed the Danek 3-D TSRH Spinal System caused her to suffer serious and life threatening injuries.According to Law360, the Danek 3-D TSRH Spinal was recalled by the U.S. Food & Drug Administration (FDA) because of a manufacturing defect that could cause the implant to...

Medtronic Says California Seeking Info on Heart Rhythm Devices

Dec 10, 2009 | Parker Waichman LLP
Medtronic Inc. is being investigated in California over its heart rhythm devices.  According to The Wall Street Journal, Medtronic recently disclosed that it had received a subpoena from the Department of Health and Human Services' Office of Inspector General in California.Medtronic reported the subpoena in a quarterly filing with the Securities and Exchange Commission (SEC) it had made on Wednesday.  The disclosure read as follows:"On September 16, 2009, the Company received a...

Medtronic Cardiac Rhythm Disease Management Site Gets FDA Warning Letter

Nov 19, 2009 | Parker Waichman LLP
Device maker giant, Medtronic, Inc., just announced that it received a warning letter from the U.S. Food & Drug Administration (FDA).According to the Twin Cities Business Journal, the letter came after an inspection of Medtronic’s Mounds View Cardiac Rhythm Disease Management site and concerned: “Corrective and preventative action and field-action timeliness, review and documentation of field action recommendations, supplier qualification and controls, and medical-device...

Grassley Putting More Heat on Spine Surgeon with Medtronic Ties

Sep 23, 2009 | Parker Waichman LLP
Senator Charles Grassley (R-Iowa) has expanded his investigation of  Dr. David Polly.  As we've reported previously, the relationship between Dr. Polly, head of spine surgery at the University of Minnesota, and  Medtronic Inc. has been under scrutiny.Grassley's probe of Dr. Polly has already revealed that he had been paid $1.2 million by Medtronic between 2003 and 2007 for consulting work. Dr. Polly had come under fire in July for not disclosing his relationship with Medtronic...

More Medtronic SynchroMed Implantable Pump Recall News